慢性前列腺炎症状指数的临床应用(英文)

Clinical use of chronic prostatitis symptom index

目的 采用美国国立卫生研究所 (NIH)制定的慢性前列腺炎症状指数 (CPSI)评估特拉唑嗪治疗慢性前列腺炎 /慢性盆腔疼痛综合症 (CPPS)的临床疗效。方法 应用特拉唑嗪 2～ 4mg治疗CPPS 68例 ,疗程 6周。采用NIH -CPSI对治疗结果进行评估。结果 用药 6周后 ,CPSI分值平均下降了 16.6分 (P <0 .0 1)。结论 特拉唑嗪是治疗CPPS的有效药物 ,与炎症性CPPS比较 。

Objective: To verify the clinical effects of terazosin on chronic prostatitis/chronic pelvic pain syndrome (CPPS).Methods:68 cases of CPPS were treated with 2 to 4 mg terazosin daily for 6 weeks, and its effects was evaluated by the chronic prostatitis symptom index (CPSI).Results: 6 weeks after administration, CPSI scores decreased by 16.6 ( P <0.01). Conclusions:It suggests that terazosin is effective for CPPS, and it is more effective to noninflammatory CPPS than to inflammatory CPPS.